Happy Easter to all celebrating. Wishing you a peaceful and enjoyable holiday.

One Day to Go! Optimizing iPSC Therapies Webinar – April 23, 2025 Join us tomorrow at 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST for a deep dive into optimizing iPSC manufacturing. 🔹Register now to secure your spot! hubs.la/Q03h9cVp0

New Orleans, we’re coming for you — twice! The RoslinCT team will be attending ISCT 2025 and ASGCT 2025 to connect, collaborate, and explore the future of cell and gene therapy. 📍 If you’re attending either event, we’d love to meet. 📅 Get in touch: lnkd.in/gfNtC62Z

At the MSCRF Showcase, RoslinCT’s Dr. Jessica Carmen and Children's National Hospital’s Patrick Hanley, Ph.D. went head-to-head in a powerful Oxford-style debate on two critical models shaping the future of cell therapy: lnkd.in/efPTt-rw

Catherine Tomaro-Duchesneau, PhD, Senior Director of Manufacturing and MS&T at RoslinCT, will deliver the keynote at Proteintech Group Group’s Cell Therapy Symposium! 🗓️ Date: May 29, 2025 🔗 Free Registration: lnkd.in/e3MZwaRv

Heading to ASGCT? Our CCO, Jessica Carmen, will be there on Wednesday and Thursday and is available to connect. If you're interested in partnering or learning more about how we can support your cell and gene therapy programs, get in touch!: lnkd.in/e6zW4H-h

Developing immunotherapies is complex. Scaling them shouldn’t be. Our integrated services support you from early process development through to late-phase and commercial manufacturing - ensuring quality, consistency, and regulatory compliance. hubs.la/Q03mttV40

Don't miss Catherine Tomaro-Duchesneau, PhD, Senior Director of Manufacturing and MS&T at RoslinCT, delivering the keynote at Proteintech Group’s Cell Therapy Symposium on May 29th! 🔗 Free Registration: lnkd.in/e3MZwaRv

Transitioning from clinical development to commercial manufacturing in cell therapy demands more than increased capacity-it requires meticulous control and scientific precision. Interested in learning how RoslinCT can support you? Let's connect: lnkd.in/e6zW4H-h

Heading to BIO 2025 in Boston? Our CEO Peter Coleman and CCO Jessica Carmen will be attending the BIO International Convention from June 16–19 at the Boston Convention & Exhibition Center. Contact us to schedule a meeting—we’d love to connect: hubs.la/Q03qFgnb0

Today is World Environment Day and at RoslinCT, we have commitments in place to reduce our waste footprint by managing procurement, segregating waste, implementing recycling schemes and working with our suppliers to find sustainable solutions: lnkd.in/e6mPGN5C

Don’t miss our Senior Director of Manufacturing & MS&T joining a thought-provoking panel discussion alongside Leopold Bertea, CTO, Mendus and Rui Tostoes, VP CMC, ImmuneBridge. Thursday, June 12 at 11:30 am Panel Discussion: Key Considerations for Commercial Scale Manufacturing

At RoslinCT, we bring the expertise, scale, and strategy needed to take your cell therapy from bench to bedside. Let’s talk Clinical & Commercial Manufacturing: roslinct.com/contact/

Cell therapies are living drugs - and their manufacture demands an equally dynamic supply chain. RoslinCT offers end-to-end GMP manufacturing with assured traceability, integrated quality systems, and secure storage and logistics. roslinct.com/cell-therapy-c…

That’s a wrap on hashtag#BIO2025! Incredible energy, inspiring conversations, and endless possibilities for the future of biotech. Thanks to everyone who made time to meet — exciting things ahead! Get in touch with us: lnkd.in/e6zW4H-h

While things were buzzing at BIO... we found a moment to connect. Thank you to everyone who joined us at our Cell & Gene Connect event—co-hosted with our fantastic partners at Miltenyi Biotec. Swipe through to catch some of the fun!

🌈 RoslinCT teams celebrated Pride with joy and creativity—from bake sales to rock painting—honouring love, inclusion, and belonging every day.

At RoslinCT, commercial manufacturing is about more than capacity. We understand what it takes to bring advanced therapies to market because we’ve built the systems, teams, and infrastructure to make it happen. Partner with us: lnkd.in/e6zW4H-h

At RoslinCT, we bring the expertise, scale, and strategy needed to take your cell therapy from bench to bedside. Let’s talk Clinical & Commercial Manufacturing: hubs.la/Q03BVH2P0

Tech transfer isn’t just a handoff - it’s a high-stakes moment. When your cell therapy hits a critical stage, will your CDMO rise to the challenge? At RoslinCT, we treat tech transfer as a science. Because your process is your IP - and we protect it like it’s our own.